ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
10.58
+0.17 (1.63%)
Sep 30, 2025, 3:04 PM CST
SHE:300254 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 92.41 | 149.52 | 132 | 263.95 | 107.26 | 188.44 | Upgrade |
Cash & Short-Term Investments | 92.41 | 149.52 | 132 | 263.95 | 107.26 | 188.44 | Upgrade |
Cash Growth | -36.06% | 13.27% | -49.99% | 146.09% | -43.08% | 24.50% | Upgrade |
Accounts Receivable | 166.97 | 176.7 | 119.5 | 107.67 | 132.18 | 201.19 | Upgrade |
Other Receivables | 17.98 | 17.62 | 13.58 | 8.44 | 10.58 | 34.39 | Upgrade |
Receivables | 184.94 | 194.32 | 133.09 | 116.11 | 142.76 | 235.58 | Upgrade |
Inventory | 149.94 | 132.79 | 120.83 | 103.26 | 108.38 | 122.44 | Upgrade |
Prepaid Expenses | - | 2.49 | 2.49 | - | - | - | Upgrade |
Other Current Assets | 29.08 | 21.75 | 18.14 | 24.72 | 17.49 | 32.45 | Upgrade |
Total Current Assets | 456.38 | 500.87 | 406.55 | 508.03 | 375.89 | 578.91 | Upgrade |
Property, Plant & Equipment | 306.26 | 306.56 | 297.52 | 356.42 | 386.14 | 398.68 | Upgrade |
Long-Term Investments | 101.19 | 101.19 | 101.72 | 86.03 | 90.92 | 82.83 | Upgrade |
Goodwill | 311.99 | 311.99 | 316.25 | 320.35 | 339.93 | 359.53 | Upgrade |
Other Intangible Assets | 177.45 | 188.05 | 194.13 | 204.22 | 220.55 | 255.01 | Upgrade |
Long-Term Deferred Tax Assets | 24.88 | 27.62 | 20.17 | 10.92 | 12.11 | 30.09 | Upgrade |
Long-Term Deferred Charges | 30.48 | 24.05 | 19.16 | 19.88 | 15.67 | 5.09 | Upgrade |
Other Long-Term Assets | 87.75 | 87.41 | 77.56 | 78.57 | 85.6 | 90.38 | Upgrade |
Total Assets | 1,496 | 1,548 | 1,433 | 1,584 | 1,527 | 1,801 | Upgrade |
Accounts Payable | 64.97 | 52.62 | 36.79 | 40.89 | 47.35 | 68.22 | Upgrade |
Accrued Expenses | 28.43 | 44.46 | 50.68 | 54.27 | 57.01 | 58.76 | Upgrade |
Short-Term Debt | 130.92 | 127.94 | 67.43 | 57.67 | 91.03 | 100.53 | Upgrade |
Current Portion of Long-Term Debt | 138.01 | - | - | 33.84 | 93.73 | 98.86 | Upgrade |
Current Portion of Leases | 8.06 | - | - | 1.9 | 5.85 | - | Upgrade |
Current Income Taxes Payable | 3.84 | 9.51 | 1.97 | 4.65 | 3.58 | - | Upgrade |
Current Unearned Revenue | 28.93 | 25.66 | 22.95 | 38.23 | 22.95 | 30.36 | Upgrade |
Other Current Liabilities | 83.79 | 310.6 | 242.54 | 368.23 | 78.53 | 133.17 | Upgrade |
Total Current Liabilities | 486.95 | 570.81 | 422.37 | 599.68 | 400.03 | 489.9 | Upgrade |
Long-Term Debt | 167 | 153.3 | 139.9 | 174.52 | 33.04 | 106.56 | Upgrade |
Long-Term Leases | 27.27 | 30.32 | 18.89 | 20.99 | 5.94 | - | Upgrade |
Long-Term Unearned Revenue | 16.82 | 17.43 | 15.32 | 15.38 | 16.16 | 10.67 | Upgrade |
Long-Term Deferred Tax Liabilities | 43.55 | 44.44 | 47.49 | 40.53 | 40.99 | 66.67 | Upgrade |
Other Long-Term Liabilities | 229.62 | 133.24 | 10.68 | 3.61 | 286.07 | 254.11 | Upgrade |
Total Liabilities | 971.21 | 949.55 | 654.64 | 854.7 | 782.23 | 927.91 | Upgrade |
Common Stock | 248.32 | 248.32 | 241.62 | 241.62 | 227.97 | 227.97 | Upgrade |
Additional Paid-In Capital | 259.79 | 349.58 | 623.91 | 623.91 | 533.47 | 539.72 | Upgrade |
Retained Earnings | -222.83 | -223.21 | -265.4 | -290.59 | -172.03 | -80.6 | Upgrade |
Treasury Stock | -31.69 | -31.69 | - | - | - | - | Upgrade |
Total Common Equity | 253.6 | 343 | 600.13 | 574.94 | 589.41 | 687.1 | Upgrade |
Minority Interest | 271.58 | 255.18 | 178.3 | 154.77 | 155.17 | 185.51 | Upgrade |
Shareholders' Equity | 525.18 | 598.18 | 778.43 | 729.71 | 744.58 | 872.61 | Upgrade |
Total Liabilities & Equity | 1,496 | 1,548 | 1,433 | 1,584 | 1,527 | 1,801 | Upgrade |
Total Debt | 471.27 | 311.56 | 226.22 | 288.92 | 229.59 | 305.95 | Upgrade |
Net Cash (Debt) | -378.86 | -162.05 | -94.21 | -24.97 | -122.33 | -117.51 | Upgrade |
Net Cash Per Share | -1.58 | -0.67 | -0.39 | -0.11 | -0.54 | -0.55 | Upgrade |
Filing Date Shares Outstanding | 248.32 | 248.32 | 241.62 | 241.62 | 227.97 | 227.97 | Upgrade |
Total Common Shares Outstanding | 248.32 | 248.32 | 241.62 | 241.62 | 227.97 | 227.97 | Upgrade |
Working Capital | -30.57 | -69.94 | -15.82 | -91.65 | -24.14 | 89.01 | Upgrade |
Book Value Per Share | 1.02 | 1.38 | 2.48 | 2.38 | 2.59 | 3.01 | Upgrade |
Tangible Book Value | -235.84 | -157.04 | 89.75 | 50.36 | 28.93 | 72.56 | Upgrade |
Tangible Book Value Per Share | -0.95 | -0.63 | 0.37 | 0.21 | 0.13 | 0.32 | Upgrade |
Buildings | 185.53 | 210.74 | 217.38 | 230.56 | 231.09 | 232.29 | Upgrade |
Machinery | 361.28 | 359 | 347.77 | 384.06 | 357.17 | 333.13 | Upgrade |
Construction In Progress | 32.89 | 15.28 | 6.64 | 44.6 | 73.93 | 86.27 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.